NCT06880198View on ClinicalTrials.gov

Study to Evaluate Impact® as Support to Anti PD1 or Anti PD1 Based Regimen Treatment in Patients With Inoperable Locally Advanced or Metastatic Melanoma

NARecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

July 31, 2027

Study Completion Date

July 31, 2027

Conditions

Melanoma MetastaticLocally Advanced Melanoma

Interventions

DIETARY_SUPPLEMENT

Oral Impact®

One Arm: 2 Impact brick/d for 21 days + 1 brick/d for 14 days, starting exactly one week before Anti PD-1 treatment in patients with inoperable locally advanced or metastatic melanoma Treatment duration: 35 days

Trial Locations (1)

80131

RECRUITING

"Istituto Nazionale Tumori IRCCS - Fondazione G. Pascale", Napoli

All Listed Sponsors

lead

Fondazione Melanoma Onlus

OTHER